Preview

Pacific Medical Journal

Advanced search

Left ventricle myocardial hypertrophy: the probability of occurrence and duration

https://doi.org/10.17238/PmJ1609-1175.2017.1.52-55

Abstract

Objective. The objective is to determine the probability and time of development of left ventricular myocardial hypertrophy (LVMH), depending on the impact of its predictor. Methods. The study of 2008-2013 involved 7959 workers aged 18-66 years of locomotive brigades of Trans-Baikal Railway, who suffered from cardiovascular diseases with the exception of essential hypertension 1 degree of stage I-II. We searched for risk factors, target lesions of cardiovascular disease with determination from among the predictors of LVMH. Results. In the first stage of research for LVMH established the following predictors: hypertension, age, retinopathy, diabetes, thickening of the complex «intima-media» more than 0.9 mm / atherosclerotic plaques of carotid arteries, body mass index greater than 25, aortic atherosclerosis, hyperglycemia and stress. The second stage was analyzed the survival function. Graphical evaluation of Kaplan-Meier method showed that it was dependent on the body mass index, presence of hypertension, hyperglycemia, retinopathy, arteriosclerosis of the aorta, carotid arteries subclinical and age. Stress as an independent risk factor had no value. Conclusions. Predictors of LVMH in its subclinical characteristics are heterogeneous in size damaging impact, the implementation of progressive course of endothelial dysfunction through an independent impact, or in combination with other predictors. LVMH is determined by the influence of not only traditional risk factors, but also the mutual negative effect of target organ damage.

About the Authors

A. Yu. Lazutkina
Regional management office of medical supply on Trans-Baikal Railway
Russian Federation


V. V. Gorbunov
Chita State Medical Academy
Russian Federation


References

1. Волобуев А.Н., Петров Е.С. Возрастное развитие синдрома SAD и первичная артериальная гипертония // Здоровье и образование в XXI веке. 2013. Т. 15, № 1-4. С. 360-361.

2. Гребенкина И.А., Попова А.А., Яковлева И.В. [и др.]. Критерий прогрессирующей дисфункции эндотелия сосудов у пациентов с артериальной гипертонией // Сибирское медицинское обозрение. 2011. Т. 71, № 5. С. 13-17.

3. Диагностика и лечение артериальной гипертензии. Рекомендации РМОАГ и ВНОК // Кардиоваскулярная терапия и профилактика. 2008. Т. 7, № 6. Прил. 2. С. 1-32.

4. Кардиоваскулярная профилактика. Рекомендации ВНОК // Кардиоваскулярная терапия и профилактика. 2011. Т.10, № 6. Прил. 2 С. 1-64.

5. Килесса В.В. Инфаркт миокарда - следствие внутрисердечного перераспределения микроциркуляторного кровотока? // Таврический мед.-биол. вестник. 2010. Т. 13, № 4. С. 209-213.

6. Лазуткина А.Ю., Горбунов В.В. Факторы риска и прогрессирования гипертрофии миокарда левого желудочка // Сара товский научно-медицинский журнал. 2015. № 2. С. 141-145.

7. Стропус Р.А. Холинергическая и адренергическая иннервация сердца и ее изменения при сердечно-сосудистой патологии: автореф. дис.. д-ра мед. наук. М., 1982. 35 с.

8. Швалев В.Н., Сосунов А.А. Гуски Г. Морфологические основы иннервации сердца. М.: Наука, 1992. 365 с.

9. Швалев В.Н., Тарский Н.А. Феномен ранней возрастной инволюции симпатического отдела вегетативной нервной системы // Кардиология. 2001. № 2. С. 10-14.

10. Aird W.C. Endothelium as an organ system // Crit. Care. Med. 2004. Vol. 32 (5 Suppl.). Р. S271-279.

11. Borchard F. The adrenergic nerves of the normal and the hypertrophied heart: biochemical, histochemical, electron-microscopic and morphometric studies. Normal and Pathologic Anatomy Series (Vol. 33). Thieme, 1978. 68 p.

12. Heil S.G, De Vriese A.S., Kluijtmans L.A. [et al.]. The role of hyperhomocysteinemia in nitric oxide (NO) and endothelium-derived hyperpolarizing factor (EDHF)-mediated vasodilatation // Cell. Mol. Biol. (Noisy-le-grand). 2004. Vol. 50, No. 8. Р. 911-916.

13. Pickering T.G. Mental stress as a casual factor in the development of hypertension and cardiovascular disease // Curr. Hypertens. Rep. 2001. No. 3. Р 249-254.

14. Schachinger V, Britten MB., Zeiger AM. Prognostic impact of coronary vasodilator dysfunction on adverse long-term outcome of coronary heart disease // Circulation. 2000. No. 101. Р. 1899-1906.

15. Sciacqua А., Borrello F., Vatrano М. [et al.]. Effect of interaction between left ventricular dysfunction and endothelial function in hypertension // Current Hypertension Reports. 2006. Vol. 8, No. 3. Р. 212-218.


Review

For citations:


Lazutkina A.Yu., Gorbunov V.V. Left ventricle myocardial hypertrophy: the probability of occurrence and duration. Pacific Medical Journal. 2017;(1):52-55. (In Russ.) https://doi.org/10.17238/PmJ1609-1175.2017.1.52-55

Views: 288


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 1609-1175 (Print)